30-03-2017 14:40 via theguardian.com

Ken Harrap obituary

Cancer researcher whose work on drug development had a major impact on life expectancyKen Harrap, who has died aged 85, was a pioneer in the development of anti-cancer drugs. The research he directed over several decades in the UK resulted in the discovery of three registered cancer drugs, carboplatin, raltitrexed and abiraterone, an outstanding achievement.When Ken was born there were no effective anti-cancer drugs and, except for patients in the early stage of the disease who could be cured by
Read more »